A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.
The ribonucleoprotein telomerase synthesizes telomeric DNA by copying an intrinsic RNA template. In most cancer cells, telomerase is highly activated. Here we report a telomerase-based antitumor strategy: expression of mutant-template telomerase RNAs in human cancer cells. We expressed mutant-template human telomerase RNAs in prostate (LNCaP) and breast (MCF-7) cancer cell lines. Even a low threshold level of expression of telomerase RNA gene constructs containing various mutant templates, but not the control wild-type template, decreased cellular viability and increased apoptosis. This occurred despite the retention of normal levels of the endogenous wild-type telomerase RNA and endogenous wild-type telomerase activity and unaltered stable telomere lengths. In vivo tumor xenografts of a breast cancer cell line expressing a mutant-template telomerase RNA also had decreased growth rates. Therefore, mutant-template telomerase RNAs exert a strongly dominant-negative effect on cell proliferation and tumor growth. These results support the potential use of mutant-template telomerase RNA expression as an antineoplastic strategy.
Kim
M M
MM
Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143-0448, USA.
Rivera
M A
MA
Botchkina
I L
IL
Shalaby
R
R
Thor
A D
AD
Blackburn
E H
EH
D002455:Cell Division / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology*; D012313:RNA / Q000235:genetics*; D019098:Telomerase / Q000235:genetics*; D013698:Templates, Genetic; D014407:Tumor Cells, Cultured
D012313:RNA; D019098:Telomerase